Number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, March 31, 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number of shares and votes in NeuroVive of 23,328. This is a result of a performed subscription options program (series 2016/2017:1).Today, the last trading day of the month, there are in total 49,481,973 shares and votes in NeuroVive. For further information, please visit the NeuroVive web site www.neurovive.com .